Ownership Submission
FORM 3
 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Expires: January 31, 2005
Estimated average burden hours per response... 0.5

(Print or Type Responses)
1. Name and Address of Reporting Person *
  Brown Jade
 2. Date of Event Requiring Statement (Month/Day/Year)
08/19/2005		 3. Issuer Name and Ticker or Trading Symbol
CELL THERAPEUTICS INC [CTIC]
(Last)
(First)
(Middle)
501 ELLIOTT AVE. W., SUITE 400		 4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director _____ 10% Owner
__X__ Officer (give title below) _____ Other (specify below)
EVP, Chief Business Officer
 5. If Amendment, Date Original Filed(Month/Day/Year)
(Street)

SEATTLE, WA 98119		 6. Individual or Joint/Group Filing(Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
(City)
(State)
(Zip)
Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4)		 2. Amount of Securities Beneficially Owned
(Instr. 4)		 3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)		 4. Nature of Indirect Beneficial Ownership
(Instr. 5)
Common Stock 60,163 (1)
D
 

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. SEC 1473 (7-02)
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 4)		 2. Date Exercisable and Expiration Date
(Month/Day/Year)		 3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)		 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)		 6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Non-Qualified Stock Option (right to buy)   (2) 06/16/2015 Common Stock 29,000 $ 2.9 D  
Non-Qualified Stock Option (right to buy)   (3) 05/21/2014 Common Stock 24,000 $ 6.95 D  
Non-Qualified Stock Option (right to buy)   (4) 02/28/2015 Common Stock 6,278 $ 9.88 D  

Reporting Owners

Reporting Owner Name / Address Relationships
Director 10% Owner Officer Other
Brown Jade
501 ELLIOTT AVE. W.
SUITE 400
SEATTLE, WA 98119		       EVP, Chief Business Officer  

Signatures

Jade Brown 08/26/2005
**Signature of Reporting Person Date

Explanation of Responses:

* If the form is filed by more than one reporting person, see Instruction 5(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1) Represents three separate grants of restricted stock which vest with dates ranging from December 16, 2005 to May 16, 2007.
(2) This option vests over a period of eighteen months from date of grant, wherein the grant shall vest 33 1/3% after 6 months, 66 2/3% after one year, and 100% after 18 months.
(3) This option vests in three equal annual installments beginning on March 29, 2005.
(4) This option vests in four annual installments as follows: 1,570 on June 1, 2005, 1,570 on March 1, 2007, 1,569 on March 1, 2008 and 1,569 on March 1, 2009.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, See Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.